We are live on ! Find out more
RAPT

RAPT Therapeutics
RAPT

Delisted

RAPT was delisted on the 2nd of March, 2026.

Back to rankings

109 hedge funds and large institutions have $842M invested in RAPT Therapeutics in 2021 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 35 increasing their positions, 23 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

344% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 9

80% more capital invested

Capital invested by funds: $468M → $842M (+$374M)

52% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 23

40% more funds holding

Funds holding: 78 → 109 (+31)

33% more funds holding in top 10

Funds holding in top 10: 9 → 12 (+3)

0.74% more ownership

Funds ownership: 10.61% → 11.34% (+0.74%)

2% less call options, than puts

Call options by funds: $53.3M | Put options by funds: $54.3M

Holders
109
Holders Change
+31
Holders Change %
+39.74%
% of All Funds
1.9%
Holding in Top 10
12
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+33.33%
% of All Funds
0.21%
New
40
Increased
35
Reduced
23
Closed
9
Calls
$53.3M
Puts
$54.3M
Net Calls
-$1.02M
Net Calls Change
-$14.2M

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$23.7M
2
GTC
Ghost Tree Capital
New York
+$13.3M
3
KCM
Kingdon Capital Management
New York
+$12.8M
4
CM
Caption Management
Oklahoma
+$9.83M
5
VA
VR Adviser
New York
+$9.13M

Top Sellers

Rank Fund Capital Flow
1
KXA
KPCB XV Associates
California
-$15.2M
2
ROTUOC
Regents of the University of California
California
-$5.08M
3
ACP
Acuta Capital Partners
California
-$4.45M
4
Millennium Management
Millennium Management
New York
-$1.84M
5
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board
Ontario, Canada
-$1.55M
Name Holding Trade Value Shares
Change 		Change in
Stake
MWNA
26
Marshall Wace North America
New York
$4.8M +$3.53M +18,887 New
MIM
27
Monashee Investment Management
Massachusetts
$4.77M +$3.5M +18,750 New
PIM
28
Ponoi II Management
California
$4.62M – – –
CCM
29
CAAS Capital Management
New York
$4.08M +$3M +16,060 New
MS
30
Maven Securities
Jersey
$3.98M +$2.79M +14,938 New
Two Sigma Advisers
31
Two Sigma Advisers
New York
$3.9M +$1.51M +8,062 +111%
VOYA Investment Management
32
VOYA Investment Management
Georgia
$3.86M -$41.9K -224 -1%
PCM
33
Pentwater Capital Management
Florida
$3.34M +$1.75M +9,375 +250%
AIIC
34
AJU IB Investment Company
South Korea
$3.16M -$210K -1,125 -8%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
35
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$2.94M +$2.16M +11,575 New
EI
36
EAM Investors
California
$2.64M +$1.94M +10,378 New
Goldman Sachs
37
Goldman Sachs
New York
$2.57M +$1.65M +8,824 +689%
Charles Schwab
38
Charles Schwab
California
$2.57M +$345K +1,845 +22%
TOCUITCONY
39
Trustees of Columbia University in the City of New York
New York
$2.49M +$113K +603 +7%
Marshall Wace
40
Marshall Wace
United Kingdom
$2.46M +$1.81M +9,693 New
TD Asset Management
41
TD Asset Management
Ontario, Canada
$2.39M +$306K +1,640 +20%
SG Americas Securities
42
SG Americas Securities
New York
$2.35M +$1.72M +9,221 New
Bank of New York Mellon
43
Bank of New York Mellon
New York
$2.26M +$581K +3,110 +54%
LCM
44
Laurion Capital Management
New York
$1.89M +$1.39M +7,432 New
EGI
45
EAM Global Investors
California
$1.76M +$1.29M +6,910 New
D.E. Shaw & Co
46
D.E. Shaw & Co
New York
$1.52M +$1.12M +5,985 New
Norges Bank
47
Norges Bank
Norway
$1.47M +$1.08M +5,788 New
Balyasny Asset Management
48
Balyasny Asset Management
Illinois
$1.45M +$1.06M +5,697 New
Simplex Trading
49
Simplex Trading
Illinois
$1.42M +$1.04M +5,586 New
CL
50
CSS LLC
Illinois
$1.39M +$1.02M +5,476 New
1
2
3 4 5

RAPT Hedge Fund Activity: Q2 2021 in Review

109 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in RAPT Therapeutics (RAPT) for Q2 2021, worth a combined $842M — up 80% from $468M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new RAPT positions and 9 closed out — a net gain of 31 holders — while 35 added to existing stakes and 23 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $23.7M. The largest seller was KPCB XV Associates, cutting an estimated $15.2M.

  • 109 institutional investors held RAPT Therapeutics (RAPT) as of Q2 2021, up from 78 in Q1 2021.
  • Funds reported $842M of RAPT Therapeutics stock for Q2 2021, up 80% quarter-over-quarter.
  • 40 funds opened new RAPT Therapeutics positions in Q2 2021 and 9 closed out, a net change of +31 holders.
  • The largest RAPT Therapeutics buyer in Q2 2021 was T. Rowe Price Associates, an estimated $23.7M added.
  • The largest RAPT Therapeutics seller in Q2 2021 was KPCB XV Associates, an estimated $15.2M sold.

Based on aggregated 13F filings for Q2 2021.